Related Experiment Videos
Interstitial nephritis associated with 5-aminosalicylic acid
T Witte1, C J Olbricht, K M Koch
1Division of Nephrology, Medical School Hannover, Germany.
Nephron
|January 1, 1994
Summary
This study reports a case of interstitial nephritis in a patient with Crohn's disease treated with 5-aminosalicylic acid (5-ASA). Discontinuation of 5-ASA led to partial recovery of kidney function, suggesting a causal link.
Area of Science:
- Nephrology
- Gastroenterology
- Pharmacology
Background:
- Crohn's disease is a chronic inflammatory bowel condition.
- 5-aminosalicylic acid (5-ASA) is a common treatment for inflammatory bowel diseases.
- Drug-induced kidney injury is a significant clinical concern.
Observation:
- A patient with severe Crohn's disease developed worsening renal function after starting 5-ASA therapy.
- Serum creatinine levels rose significantly, indicating impaired kidney clearance.
- Renal biopsy confirmed interstitial nephritis with mononuclear infiltrates and normal glomeruli.
Findings:
- Discontinuation of 5-ASA resulted in a decrease in serum creatinine and improved creatinine clearance.
- The absence of other nephrotoxic agents supported 5-ASA as the likely cause.
- This case highlights a potential adverse effect of 5-ASA on renal function.
Implications:
- Clinicians should monitor renal function in patients treated with 5-ASA, especially those with pre-existing kidney conditions.
- Early recognition and discontinuation of 5-ASA may prevent irreversible renal damage.
- Further research is warranted to understand the mechanisms of 5-ASA-induced nephrotoxicity.